Newt talks with Anthony Esposito, CEO of Island Capital Investments, about the current stock market volatility, the Federal Reserve’s role, and the impact of tariffs.
Newt talks with Anthony Esposito, founder and CEO of Island Capital Investments, about the current stock market volatility, the Federal Reserve’s role, and the impact of tariffs. Esposito shares insights from his technical analysis model, predicting a bear market and emphasizing the need for structural economic changes. He critiques past and present Federal Reserve policies, highlighting the importance of focusing on price stability. Their conversation also covers the broader implications of tariffs and trade deficits, suggesting that the U.S. is poised for significant economic growth due to substantial onshoring and investment. Esposito underscores the importance of objective market analysis and shares his investment strategy, which currently leans towards short positions until market conditions stabilize.
Guest:
Anthony Esposito
- Mamdani’s Voter Base of Young, Superficially Educated Elites Is the Real Story of New York’s Mayoral RaceIgnorant of history and indoctrinated by leftism, these voters forget Thatcher’s warning: ‘The problem with socialism is that you eventually run out of other people’s money.’
- Beyond the August RecessWhen Congress recesses for summer, Republican members and senators have an opportunity to really shift the national dialogue about spending, savings, deficits, and taxes.
- Trump’s Triumph: America’s Greatest ComebackIn this New York Times bestseller, author Newt Gingrich takes readers inside the most significant political comeback in American history and explains where the Trump movement goes from here.
- Newt’s World Episode 873: Salena Zito on ButlerNewt talks with veteran political reporter Salena Zito about her new book, Butler: The Untold Story of the Near Assassination of Donald Trump and the Fight for America’s Heartland.
- Newt’s World Episode 872: Ibogaine – Inside a Treatment FacilityNewt talks with Jonathan Dickinson, CEO and José Inzunza, Chief Medical Officer, Co-Founders of Ambio Life Sciences, a global leader in integrative ibogaine treatment.